DSM updates market on strategy progress at Capital Markets Days
(Thomson Reuters ONE) -
Royal DSM, the global Life Sciences and Materials Sciences company, today and
tomorrow will update the financial community at its annual Capital Markets Days
on the progress made with its DSM in Motion: driving focused growth strategy.
The company also confirms its 2011 outlook.
Feike Sijbesma, CEO and Chairman of the DSM Managing Board, commented: "Against
a backdrop of increased uncertainties related to the global economy, our
completed transformation into a Life Sciences and Materials Sciences company has
positioned DSM well with a balanced, relatively resilient portfolio in health,
nutrition and materials. We are making good progress in executing our strategy
and we are on track to achieve our 2013 targets."
During today's conference, DSM will update the investment community on progress
made with DSM in motion: driving focused growth. This strategy marks the shift
from an era of intensive portfolio transformation to a strategy for the coming
years of maximizing sustainable and profitable growth of 'the new DSM'. The
company believes good progress is being made towards achieving the EBITDA target
of ? 1.4 to 1.6 billion in 2013, in conjunction with a ROCE of more than 15%.
The following information will be given:
· DSM is on track in achieving its ambitious financial targets for 2013
and 2015
· DSM reports good progress towards achieving its sustainability
aspirations, recently it was named once again the supersector leader in the Dow
Jones Sustainability Index
· Nutrition: good progress is achieved with the integration and profit
growth of Martek; the strong Swiss Franc impacts the results of the cluster also
in Q3; the cluster is on track regarding its growth strategy
· Pharma: the just established DSM Sinochem Pharmaceuticals-JV aims to
increase its sales to > ? 600 mln with an EBITDA margin > 15% by 2015; a
partnership for DPP is being pursued
· Performance Materials: strong growth is based on innovative sustainable
solutions enhanced by selective acquisitions & partnerships
· Polymer Intermediates: will further strengthen its global leadership
position; 2(nd) production line in China is being built
· Bio-based Products & Services: with number one position in yeast and top
3 position in enzymes DSM is well positioned for 2(nd) generation (cellulosic)
bio-ethanol; a large scale bio-based succinic acid plant is under construction
· Biomedical: continued strong growth (> 15% per year) anticipated
· DSM confirms outlook: 2011 is expected to be a strong year; good
progress towards achieving the 2013 targets, assuming no major changes to the
overall business assumptions for the full year
Webcast
The DSM Capital Markets Days can be followed today from 15.30 until 18.00 hrs
(CET) via an audio webcast. The presentations can be downloaded from DSM's
website as of 13.00 hrs (CET). For a link see the Investors section on
www.dsm.com
DSM - Bright Science. Brighter Living.(TM)
Royal DSM N.V. is a global science-based company active in health, nutrition and
materials. By connecting its unique competences in Life Sciences and Materials
Sciences DSM is driving economic prosperity, environmental progress and social
advances to create sustainable value for all stakeholders. DSM delivers
innovative solutions that nourish, protect and improve performance in global
markets such as food and dietary supplements, personal care, feed,
pharmaceuticals, medical devices, automotive, paints, electrical and
electronics, life protection, alternative energy and bio-based materials. DSM's
22,000 employees deliver annual net sales of about ?9 billion. The company is
listed on NYSE Euronext. More information can be found at www.dsm.com
For more information:
DSM Corporate Communications DSM Investor Relations
Herman Betten Hans Vossen
tel. +31 (0) 45 5782017 tel. +31 (0) 45 5782864
fax +31 (0) 45 5740680 fax +31 (0) 10 4590275
e-mail media.relations(at)dsm.com e-mail investor.relations(at)dsm.com
Press release-pdf:
http://hugin.info/130663/R/1550709/477456.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: DSM N.V. via Thomson Reuters ONE
[HUG#1550709]
Unternehmensinformation / Kurzprofil:
Datum: 29.09.2011 - 08:16 Uhr
Sprache: Deutsch
News-ID 69856
Anzahl Zeichen: 5293
contact information:
Town:
Heerlen
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 205 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DSM updates market on strategy progress at Capital Markets Days"
steht unter der journalistisch-redaktionellen Verantwortung von
DSM N.V. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
